Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allogene Therapeutics Inc (NQ: ALLO ) 2.610 +0.020 (+0.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Allogene Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease March 12, 2024 From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update March 05, 2024 Conference Call and Webcast Scheduled for March 14, 2024 at 2:00 p.m. PT/5:00 p.m. ET From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference February 28, 2024 From Allogene Therapeutics, Inc. Via GlobeNewswire Earnings Outlook For Allogene Therapeutics November 01, 2023 Via Benzinga Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia February 16, 2024 From Allogene Therapeutics, Inc. Via GlobeNewswire CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday February 12, 2024 U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) rose sharply in today’s pre-market trading. Via Benzinga Topics Stocks Exposures US Equities Allogene Therapeutics Announces Participation in Upcoming Investor Conferences January 16, 2024 From Allogene Therapeutics, Inc. Via GlobeNewswire Cell Therapy Focused Allogene Therapeutics' Resource Prioritization A Bold Move, Says Analyst January 05, 2024 Allogene Therapeutics Inc (NASDAQ: ALLO) announced deprioritizing the currently enrolling third line Phase 2 ALPHA2 and EXPAND trials of cema-cel (ALLO-501A) and is now pursuing a potentially pivotal... Via Benzinga Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Shares of Applied Therapeutics, Inc. Via Benzinga Allogene Layoffs 2024: What to Know About the Latest ALLO Job Cuts January 05, 2024 Today, investors in Allogene and ALLO stock aren't cheering a cash burn reduction strategy, with the stock sinking over 15% on the news. Via InvestorPlace Topics Workforce Exposures Layoff Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 05, 2024 Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! Via InvestorPlace Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session January 05, 2024 U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's After-Market Session January 04, 2024 Via Benzinga Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma January 04, 2024 From Allogene Therapeutics, Inc.; Foresight Diagnostics Via GlobeNewswire Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma January 04, 2024 From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Allogene Therapeutics, Inc. Via GlobeNewswire Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday December 22, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition... Via Benzinga Topics Stocks Exposures US Equities Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Shares of Longboard Pharmaceuticals, Inc. Via Benzinga Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology December 09, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. Via Benzinga Allogene Therapeutics Announces Participation in December Investor Conference December 01, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire 7 Penny Stocks With Low Floats and High Short Interest November 24, 2023 Is the 'smart money' on the money shorting these low-float penny stocks, or is there the opportunity for a short squeeze? Let's find out. Via InvestorPlace Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 03, 2023 Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. Via Benzinga Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual Meeting November 03, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting November 03, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday November 03, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update November 02, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics Announces Poster Presentations at the 65th Annual Meeting of the American Society of Hematology November 02, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics Announces Participation in November Investor Conferences October 30, 2023 From Allogene Therapeutics, Inc. Via GlobeNewswire Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023 October 26, 2023 Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET From Allogene Therapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.